Apolipoprotein ε4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 3, 2005, Pages 375-379

  Wayne, Sharon J ^a   Vellas, Bruno J ^b   Brodie, Steven G ^a   Garry, Philip J ^a   Baumgartner, Richard N ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Acute Unit for Alzheimer's Patients   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ARTICLE; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; DEMENTIA; ERROR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ORIENTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCORING SYSTEM; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONFUSION; DEMOGRAPHY; DISEASE COURSE; FOLLOW UP; GENETIC MARKER; GENETICS; GERIATRIC ASSESSMENT; HOSPITALIZATION; METABOLISM; PHYSIOLOGY; PROBABILITY; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEINS E; COGNITION DISORDERS; COHORT STUDIES; CONFIDENCE INTERVALS; CONFUSION; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GERIATRIC ASSESSMENT; HUMANS; MALE; NEW MEXICO; ODDS RATIO; PROBABILITY; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 18244385485     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.3.375     Document Type: Article

References (24)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
2. Fairer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolioprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349-1356.
3. Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOE-E4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology. 2003;60:1077-1081.
4. Dik MG, Jonker C, Comijs HC, et al. Memory complaints and APOE-E4 accelerate cognitive decline in cognitively normal elderly. Neurology. 2001;57:2217-2222.
5. Howieson DB, Camicioli R, Quinn J, et al. Natural history of cognitive decline in the old old. Neurology. 2003;60:1489-1494.
6. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996;40:55-66.
7. Garry PJ, Goodwin JS, Hunt WC, Hooper EM, Leonard AG. Nutritional status in a healthy elderly population: dietary and supplemental intakes. Am J Clin Nutr. 1982;36:319-331.
8. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
9. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res. 1990;31:545-548.
10. Shapiro S, Weinblatt E, Frank CW, Sager RV. The HIP study of incidence and prognosis of coronary heart disease. J Chron Dis. 1965;18:527-558.
11. Kim KW, Youn JC, Jhoo JH, et al. Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals. Int J Geriatr Psychiatry. 2002;17:635-640.
12. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand. 1999;100:53-60.
13. Yaffe K, Cauley J, Sands L, Browner W. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol. 1997;54:1110-1114.
14. Bowler JV, Hadar U, Wade JP. Cognition in stroke. Acta Neurol Scand. 1994;90:424-429.
15. Narushima K, Chan KL, Kosier JT, Robinson RG. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression. Am J Psychiatry. 2003;160:1157-1162.
16. Rabins PV. The prevalence of reversible dementia in a psychiatric hospital. Hosp Community Psychiatry. 1981;32:490-492.
17. Rabins PV, Merchant A, Nestadt G. Criteria for diagnosing reversible dementia caused by depression: validation by 2-year follow-up. Br J Psychiatry. 1984;144:488-492.
18. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease. Arch Neurol. 2000;57:839-844.
19. Ercoli LM, Siddarth P, Dunkin JJ, Bramen J, Small GW. MMSE items predict cognitive decline in persons with genetic risk for Alzheimer's disease. J Geriatr Psychiatry Neurol. 2003;16:67-73.
20. Small BJ, Viitanen M, Backman L. Mini-mental state examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol. 1997;52A:M299-M304.
21. Fillenbaum GG, Wilkinson WE, Welsh KA, Mohs RC. Discrimination between stages of Alzheimer's disease with subsets of mini-mental state examination items. Arch Neurol. 1994;51:916-921.
22. Galasko D, Klauber MR, Hofstetter R, Salmon DP, Lasker B, Thal LJ. The mini-mental state examination in the early diagnosis of Alzheimer's disease. Arch Neurol. 1990;47:49-52.
23. Fillenbaum GG, Hughes DC, Heyman A, George LK, Blazer DG. Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. Psychol Med. 1988;18:719-726.
24. Jones RN, Gallo JJ. Education bias in the mini-mental state examination. Int Psycho geriatr. 2001;13:299-310.